SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-134773
Filing Date
2020-12-11
Accepted
2020-12-11 16:10:27
Documents
2
Period of Report
2020-12-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2038260d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2038260d1_3.xml 3 1621
2 EXHIBIT 24 tm2038260d1_ex24.htm EX-24 5764
  Complete submission text file 0001104659-20-134773.txt   8892
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Bedrosian Camille L (Reporting) CIK: 0001326969 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38223 | Film No.: 201383682

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations